(Q37831931)

24 August 2017

1 reference

title

Transport, stability, and biological activity of resveratrol (English)

1 reference

24 August 2017

François Ghiringhelli

6

object named as

François Ghiringhelli

0 references

author name string

Dominique Delmas

1

1 reference

24 August 2017

Virginie Aires

2

1 reference

24 August 2017

Emeric Limagne

3

1 reference

24 August 2017

Patrick Dutartre

4

1 reference

24 August 2017

Frédéric Mazué

5

1 reference

24 August 2017

Norbert Latruffe

7

1 reference

24 August 2017

language of work or name

English

0 references

publication date

1 January 2011

1 reference

Annals of the New York Academy of Sciences

24 August 2017

12

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

24 August 2017

1215

1 reference

24 August 2017

48-59

1 reference

A new class of phytoalexins from grapevines

24 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2010.05871.X

Piceid, the major resveratrol derivative in grape juices

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2010.05871.X

Evidence that the antioxidant flavonoids in tea and cocoa are beneficial for cardiovascular health

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2010.05871.X

Resveratrol: preventing properties against vascular alterations and ageing

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2010.05871.X

Resveratrol as a chemopreventive agent: a promising molecule for fighting cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2010.05871.X

High absorption but very low bioavailability of oral resveratrol in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2010.05871.X

Resveratrol inhibits metal ion-dependent and independent peroxidation of porcine low-density lipoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2010.05871.X

Cyclodextrins for drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2010.05871.X

Effects of resveratrol analogs on cell cycle progression, cell cycle associated proteins and 5fluoro-uracil sensitivity in human derived colon cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2010.05871.X

Inhibitory effects of trans-resveratrol analogs molecules on the proliferation and the cell cycle progression of human colon tumoral cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2010.05871.X

Design, synthesis and spectroscopic studies of resveratrol aliphatic acid ligands of human serum albumin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2010.05871.X

Stereospecific determination of cis- and trans-resveratrol in rat plasma by HPLC: application to pharmacokinetic studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2010.05871.X

Simple spectrophotometric assessment of the trans-/cis-resveratrol ratio in aqueous solutions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2010.05871.X

HPLC-tandem mass spectrometric method to characterize resveratrol metabolism in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2010.05871.X

Diagnostic performance of urinary resveratrol metabolites as a biomarker of moderate wine consumption.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2010.05871.X

Voglibose (Basen, AO-128), one of the most important alpha-glucosidase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2010.05871.X

Effects of trans- and cis-resveratrol on Ca2+ handling in A7r5 vascular myocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2010.05871.X

Inhibitory effects of cis- and trans-resveratrol on noradrenaline and 5-hydroxytryptamine uptake and on monoamine oxidase activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2010.05871.X

Structural determinants of resveratrol for cell proliferation inhibition potency: experimental and docking studies of new analogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2010.05871.X

Autoxidative quinone formation in vitro and metabolite formation in vivo from tea polyphenol (-)-epigallocatechin-3-gallate: studied by real-time mass spectrometry combined with tandem mass ion mapping

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2010.05871.X

Evaluation of resveratrol oxidation in vitro and the crucial role of bicarbonate ions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2010.05871.X

Instability of, and generation of hydrogen peroxide by, phenolic compounds in cell culture media

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2010.05871.X

Preformulation stability of trans-resveratrol and trans-resveratrol glucoside (Piceid).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2010.05871.X

Resveratrol mobilizes endogenous copper in human peripheral lymphocytes leading to oxidative DNA breakage: a putative mechanism for chemoprevention of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2010.05871.X

Antiproliferative activities of resveratrol and related compounds in human hepatocyte derived HepG2 cells are associated with biochemical cell disturbance revealed by fluorescence analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2010.05871.X

Human hepatic cell uptake of resveratrol: involvement of both passive diffusion and carrier-mediated process

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2010.05871.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2010.05871.X

Resveratrol analog, 3,4,5,4'-tetrahydroxystilbene, differentially induces pro-apoptotic p53/Bax gene expression and inhibits the growth of transformed cells but not their normal counterparts

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2010.05871.X

Differential binding of tetracyclines with serum albumin and induced structural alterations in drug-bound protein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2010.05871.X

Transport of resveratrol, a cancer chemopreventive agent, to cellular targets: plasmatic protein binding and cell uptake

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2010.05871.X

Resveratrol, genistein, and curcumin bind bovine serum albumin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2010.05871.X

Effect of human serum albumin on drug metabolism: structural evidence of esterase activity of human serum albumin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2010.05871.X

Interaction of transresveratrol with plasma lipoproteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2010.05871.X

Quantification of free and protein-bound trans-resveratrol metabolites and identification of trans-resveratrol-C/O-conjugated diglucuronides - two novel resveratrol metabolites in human plasma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2010.05871.X

The oxidation hypothesis of atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2010.05871.X

Integrin alphaVbeta3 contains a receptor site for resveratrol

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2010.05871.X

Resveratrol is pro-apoptotic and thyroid hormone is anti-apoptotic in glioma cells: both actions are integrin and ERK mediated

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2010.05871.X

alphavbeta3 Integrin-dependent antiangiogenic activity of resveratrol stereoisomers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2010.05871.X

Differential recognition of resveratrol isomers by the human estrogen receptor-alpha: molecular dynamics evidence for stereoselective ligand binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2010.05871.X

Resveratrol bioavailability and toxicity in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2010.05871.X

Phase I dose escalation pharmacokinetic study in healthy volunteers of resveratrol, a potential cancer chemopreventive agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2010.05871.X

Dietary phenolics: chemistry, bioavailability and effects on health

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2010.05871.X

Resveratrol in human hepatoma HepG2 cells: metabolism and inducibility of detoxifying enzymes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2010.05871.X

Metabolism and bioavailability of trans-resveratrol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2010.05871.X

Distribution of [14C]-trans-resveratrol, a cancer chemopreventive polyphenol, in mouse tissues after oral administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2010.05871.X

Metabolism and disposition of resveratrol in rats: extent of absorption, glucuronidation, and enterohepatic recirculation evidenced by a linked-rat model

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2010.05871.X

Resveratrol, pterostilbene, and piceatannol in vaccinium berries

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2010.05871.X

Determination of piceatannol in rat serum and liver microsomes: pharmacokinetics and phase I and II biotransformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2010.05871.X

The cancer preventative agent resveratrol is converted to the anticancer agent piceatannol by the cytochrome P450 enzyme CYP1B1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2010.05871.X

Involvement of cytochrome P450 1A2 in the biotransformation of trans-resveratrol in human liver microsomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2010.05871.X

Liquid chromatographic/electrospray ionization mass spectrometric identification of the oxidation end-products of trans-resveratrol in aqueous solutions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2010.05871.X

Piceatannol induces Fas and FasL up-regulation in human leukemia U937 cells via Ca2+/p38alpha MAPK-mediated activation of c-Jun and ATF-2 pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2010.05871.X

Resveratrol glucuronides as the metabolites of resveratrol in humans: characterization, synthesis, and anti-HIV activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2010.05871.X

Selective synthesis and biological evaluation of sulfate-conjugated resveratrol metabolites.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2010.05871.X

Pleiotropic mechanisms facilitated by resveratrol and its metabolites.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2010.05871.X

Resveratrol: a molecule whose time has come? And gone?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.2010.05871.X

10.1111/J.1749-6632.2010.05871.X

21 January 2018

Identifiers

DOI

1 reference

24 August 2017

1 reference